APLS - Apellis Pharmaceuticals Inc (Healthcare: Biotechnology) Projected Earnings Date: 2025-05-30    (Delayed quote data   2025-04-03)
Last
 22.52		 Change
 ⇓ -0.48   (-2.09%)		 Volume
  2,652,269
Open
 22.24		 High
 23.23		 Low
 22.00
8EMA (Daily)
 23.33		 40EMA (Daily)
 25.65		 50EMA (Daily)
 26.22		 STO (Daily)
 27.149		 MACD Hist (Daily)
 -0.137
8EMA (Weekly)
 25.092		 40EMA (Weekly)
 32.17		 50EMA (Weekly)
 34.18		 STO (Weekly)
 7.073		 MACD Hist (Weekly)
 -0.486
Company Profile
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com